InvestorsHub Logo
Followers 2
Posts 379
Boards Moderated 0
Alias Born 12/04/2016

Re: davidal66 post# 1118

Monday, 08/14/2017 7:20:40 PM

Monday, August 14, 2017 7:20:40 PM

Post# of 2099
The company keep talking about long term benefits from vb111 also in the q2 pr giving us a huge clue about what u said and about the cancel of futility analysis. The drug will be approved based on long term effect of small amount of patients. This is what they believe and the fda agree with them and this is why we see more and more delays. First it was 91 events then 105 plus 50% now they came with more delays with a funny excuse - the reason of this current delay IS the previous delay that brought the interim so closed to the end of trial that there is no reason to even do it.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent VBLT News